AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15925520 — intervention group
Group type: COMPARATOR
Intervention: Divided attention between two gaps in the first stimulus
Number of subjects: 0
Study 15925520 — intervention group
Group type: EXPERIMENTAL
Intervention: Conscious intention
Number of subjects: 0
Study 12088961 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% with epinephrine 5 microg/mL
Number of subjects: 46
Study 12088961 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 46
Study 10468078 — intervention group
Group type: EXPERIMENTAL
Intervention: Ir‐192
Number of subjects: 55
Study 10468078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 8536304 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 6 mg s.c.
Number of subjects: 138
Study 8536304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study 2196522 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard methylphenidate (twice a day)
Number of subjects: 22
Study 2196522 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release methylphenidate (SR-20 Ritalin)
Number of subjects: 22
Study 2196522 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release dextroamphetamine (Dexedrine Spansule)
Number of subjects: 22
Study 2196522 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemoline
Number of subjects: 22
Study 2196522 — intervention group
Group type: EXPERIMENTAL
Intervention: All four medications
Number of subjects: 22
Study 39539 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% dipivefrin
Number of subjects: 42
Study 39539 — intervention group
Group type: COMPARATOR
Intervention: 2% epinephrine hydrochloride
Number of subjects: 42
Study 31975354 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg once daily
Number of subjects: 0
Study 31975354 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 7.5 mg once daily
Number of subjects: 0
Study 31521337 — intervention group
Group type: EXPERIMENTAL
Intervention: Early RIPC (remote ischaemic preconditioning)
Number of subjects: 406
Study 31521337 — intervention group
Group type: COMPARATOR
Intervention: Sham RIPC (control)
Number of subjects: 406
Study 26130725 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse Case Management Plus Contingency Management (NCM + CM)
Number of subjects: 414
Study 26130725 — intervention group
Group type: COMPARATOR
Intervention: Standard Education Plus Contingency Management (SE + CM)
Number of subjects: 414
Study 26130725 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (NCM + CM and SE + CM)
Number of subjects: 414
Study 25798728 — intervention group
Group type: EXPERIMENTAL
Intervention: Turtle Program (n = 18)
Number of subjects: 40
Study 25798728 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control (WLC; n = 22)
Number of subjects: 40
Study 23448513 — intervention group
Group type: EXPERIMENTAL
Intervention: Anapen(®)
Number of subjects: 100
Study 23448513 — intervention group
Group type: COMPARATOR
Intervention: EpiPen(®)
Number of subjects: 100
Study 23448513 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 100
Study 21056606 — intervention group
Group type: EXPERIMENTAL
Intervention: Pork meal
Number of subjects: 30
Study 21056606 — intervention group
Group type: EXPERIMENTAL
Intervention: Chicken meal
Number of subjects: 30
Study 21056606 — intervention group
Group type: EXPERIMENTAL
Intervention: Beef meal
Number of subjects: 30
Study 21056606 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 30
Study 19812866 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% MSG in mashed potatoes
Number of subjects: 53
Study 19812866 — intervention group
Group type: EXPERIMENTAL
Intervention: MSG in spinach and ground beef (2%)
Number of subjects: 53
Study 19812866 — intervention group
Group type: COMPARATOR
Intervention: Foods without MSG
Number of subjects: 53
Study 16970947 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate statin treatment
Number of subjects: 48
Study 16970947 — intervention group
Group type: COMPARATOR
Intervention: Non-treated hyperlipidemic group
Number of subjects: 48
Study 16970947 — intervention group
Group type: EXPERIMENTAL
Intervention: No lipoprotein abnormalities
Number of subjects: 48
Study 15297280 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronological reading
Number of subjects: 166
Study 15297280 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired reading
Number of subjects: 166
Study 15297280 — intervention group
Group type: COMPARATOR
Intervention: Comparison between chronological and paired reading
Number of subjects: 166
Study 11730209 — intervention group
Group type: EXPERIMENTAL
Intervention: PG synthesis inhibitor (PGSI)
Number of subjects: 36
Study 11730209 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 9103301 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene
Number of subjects: 0
Study 8229035 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone (500 mg for five consecutive days)
Number of subjects: 35
Study 8229035 — intervention group
Group type: COMPARATOR
Intervention: Oral methylprednisolone (500 mg for five consecutive days)
Number of subjects: 35
Study 31679831 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture Tunnel (ST)
Number of subjects: 24
Study 31679831 — intervention group
Group type: EXPERIMENTAL
Intervention: Screw and Washer (SW)
Number of subjects: 24
Study 31679831 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture Anchor (SA)
Number of subjects: 24
Study 31207148 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational strategy intervention and remote supervision
Number of subjects: 169
Study 31207148 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 169
Study 28108578 — intervention group
Group type: EXPERIMENTAL
Intervention: Celite-guided anticoagulation
Number of subjects: 97
Study 28108578 — intervention group
Group type: COMPARATOR
Intervention: Kaolin-guided anticoagulation
Number of subjects: 97
Study 26206095 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 μg vitamin D3
Number of subjects: 613
Study 26206095 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 μg vitamin D3
Number of subjects: 613
Study 26206095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 613
Study 23642949 — intervention group
Group type: EXPERIMENTAL
Intervention: Caralluma fimbriata extract (500 mg capsules twice daily)
Number of subjects: 33
Study 23642949 — intervention group
Group type: COMPARATOR
Intervention: Placebo (500 mg capsules twice daily)
Number of subjects: 33
Study 23642949 — intervention group
Group type: EXPERIMENTAL
Intervention: Caralluma fimbriata extract
Number of subjects: 33
Study 23642949 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Caralluma fimbriata extract and placebo)
Number of subjects: 33
Study 22137514 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulating catheters (Group SC)
Number of subjects: 40
Study 22137514 — intervention group
Group type: COMPARATOR
Intervention: Nonstimulating catheters (Group NSC)
Number of subjects: 40
Study 19506494 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor imagery (MI) training program combined with conventional rehabilitation
Number of subjects: 14
Study 19506494 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 14
Study 17252909 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of pulsed low frequency magnetic field (PLFMF) with kinesitherapy
Number of subjects: 90
Study 17252909 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose of pulsed low frequency magnetic field (PLFMF) with kinesitherapy
Number of subjects: 90
Study 17252909 — intervention group
Group type: COMPARATOR
Intervention: Control group treated only with kinesitherapy
Number of subjects: 90
Study 15580064 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional counselling by dietician
Number of subjects: 503
Study 15580064 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional counselling by general practitioner (GP)
Number of subjects: 503
Study 15580064 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional counselling by GP
Number of subjects: 503
Study 10889097 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract extraction or secondary lens implantation
Number of subjects: 854
Study 9055905 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment at daily doses of 0.1, 0.2, or 0.3 IU/kg (0.033, 0.067, or 0.1 mg/kg) s.c.
Number of subjects: 244
Study 9055905 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 244
Study 1390340 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice daily oral ondansetron
Number of subjects: 0
Study 1390340 — intervention group
Group type: COMPARATOR
Intervention: Three times daily oral ondansetron
Number of subjects: 0
Study 2409278 — intervention group
Group type: EXPERIMENTAL
Intervention: 32% dextran 70 (n = 12)
Number of subjects: 22
Study 2409278 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 22
Study 2409278 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 22
Study 2409278 — intervention group
Group type: EXPERIMENTAL
Intervention: 32% dextran 70
Number of subjects: 22
Study 3493519 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-lactamase-susceptible agents
Number of subjects: 20
Study 3493519 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-lactamase-producing strains
Number of subjects: 20
Study 3493519 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 20
Study 29709434 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient music
Number of subjects: 182
Study 27794201 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate red wine intake for 1 month
Number of subjects: 20
Study 27794201 — intervention group
Group type: COMPARATOR
Intervention: Control group (no wine intake)
Number of subjects: 20
Study 25958941 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.7g CHO.kg(‐1) supplement
Number of subjects: 49
Study 25958941 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.35g CHO.kg(‐1) supplement
Number of subjects: 49
Study 25958941 — intervention group
Group type: COMPARATOR
Intervention: Dietary records of CHO intake
Number of subjects: 49
Study 23030767 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast 20 mg BID
Number of subjects: 259
Study 23030767 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast 20 mg QD
Number of subjects: 259
Study 23030767 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study 22017336 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 0
Study 22017336 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18293379 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive myeloablative chemotherapy and autologous hematopoietic progenitor cell rescue (AuHCR)
Number of subjects: 21
Study 16267121 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued targets (repeated targets)
Number of subjects: 28
Study 16267121 — intervention group
Group type: EXPERIMENTAL
Intervention: Catch targets
Number of subjects: 28
Study 16267121 — intervention group
Group type: EXPERIMENTAL
Intervention: Pursuit latency across repeated targets
Number of subjects: 28
Study 16267121 — intervention group
Group type: COMPARATOR
Intervention: Unexpected first targets
Number of subjects: 28
Study 15074452 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilation-feedback with exercise (V(+EX))
Number of subjects: 39
Study 15074452 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise only (EX(ONLY))
Number of subjects: 39
Study 15074452 — intervention group
Group type: COMPARATOR
Intervention: Ventilation-feedback only (VF(ONLY))
Number of subjects: 39
Study 10717717 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone 240 mg daily for 3 days (group B)
Number of subjects: 58
Study 10717717 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone 40 mg daily for 3 days (group C)
Number of subjects: 58
Study 10717717 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 days (group A)
Number of subjects: 58
Study 9165601 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal bladder distension (voiding postponement)
Number of subjects: 0
Study 9165601 — intervention group
Group type: COMPARATOR
Intervention: Minimal bladder filling (regular and frequent voidings)
Number of subjects: 0
Study 1312317 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (18 Max-EPA capsules daily, 3.24 g eicosapentaenoic acid, 2.16 g docosahexaenoic acid)
Number of subjects: 18
Study 1312317 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 18
Study 1312317 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 18
Study 2997764 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcrystalline hydroxyapatite compound (MCHC)
Number of subjects: 36
Study 30758848 — intervention group
Group type: EXPERIMENTAL
Intervention: GTR (Guided Tissue Regeneration) with resorbable collagen membrane
Number of subjects: 32
Study 30758848 — intervention group
Group type: COMPARATOR
Intervention: Control group (no collagen membrane)
Number of subjects: 32
Study 28382392 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicon nitride implants
Number of subjects: 100
Study 28382392 — intervention group
Group type: COMPARATOR
Intervention: PEEK cages filled with autograft
Number of subjects: 100
Study 25456166 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily 0.1-mg subcutaneous GnRHa until day of beta-HCG (n = 224)
Number of subjects: 446
Study 25456166 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily vaginal progesterone suppositories (both groups)
Number of subjects: 446
Study 25456166 — intervention group
Group type: COMPARATOR
Intervention: Stopped GnRHa on day of HCG injection (n = 222)
Number of subjects: 446
Study 23574148 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-emptive antifungal treatment
Number of subjects: 81
Study 23574148 — intervention group
Group type: COMPARATOR
Intervention: Control (no antifungal treatment)
Number of subjects: 81
Study 20097587 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 0.4 mg/kg orally twice daily for 3 weeks
Number of subjects: 0
Study 20097587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20097587 — intervention group
Group type: EXPERIMENTAL
Intervention: Protection blankets and stabling
Number of subjects: 0
Study 19072745 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior spontaneous preterm birth at <24 weeks
Number of subjects: 1014
Study 19072745 — intervention group
Group type: EXPERIMENTAL
Intervention: Most recent birth at <24 weeks
Number of subjects: 1014
Study 18007138 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepregnancy counselling and multidisciplinary team management
Number of subjects: 0
Study 18007138 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hypoglycaemics like metformin
Number of subjects: 0
Study 18007138 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with established diabetes taking folic acid
Number of subjects: 0
Study 18007138 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with established diabetes with documentation of glycaemic control before pregnancy
Number of subjects: 0
Study 18007138 — intervention group
Group type: EXPERIMENTAL
Intervention: NHS trusts providing multidisciplinary preconception services
Number of subjects: 0
Study 18007138 — intervention group
Group type: EXPERIMENTAL
Intervention: Caesarean delivery rates
Number of subjects: 0
Study 18007138 — intervention group
Group type: EXPERIMENTAL
Intervention: Congenital malformation rate
Number of subjects: 0
Study 18007138 — intervention group
Group type: EXPERIMENTAL
Intervention: Perinatal mortality rate
Number of subjects: 0
Study 18007138 — intervention group
Group type: EXPERIMENTAL
Intervention: Stillbirth rate
Number of subjects: 0
Study 18007138 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant mortality in the first 3 months of life
Number of subjects: 0
Study 15096078 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (up to 40 mg/day)
Number of subjects: 20
Study 15096078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 11917051 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 8 mg added to ACEI regimen
Number of subjects: 60
Study 10178713 — intervention group
Group type: EXPERIMENTAL
Intervention: iMg++ group (n=65)
Number of subjects: 150
Study 10178713 — intervention group
Group type: COMPARATOR
Intervention: tMg++ group (n=85)
Number of subjects: 150
Study 7657007 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectant management with tocolysis for 48 hours if necessary (Group A)
Number of subjects: 241
Study 7657007 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive tocolysis (Group B)
Number of subjects: 241
Study 2495811 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 75 micrograms kg‐1
Number of subjects: 20
Study 2495811 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 20
Study 737474 — intervention group
Group type: EXPERIMENTAL
Intervention: Guar crispbread
Number of subjects: 9
Study 30946525 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg extended-release tolterodine at bedtime
Number of subjects: 172
Study 30946525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study 30946525 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine
Number of subjects: 172
Study 27714955 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium diet (lowNa)
Number of subjects: 9
Study 27714955 — intervention group
Group type: COMPARATOR
Intervention: High-sodium diet (highNa)
Number of subjects: 9
Study 25960284 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (andrographolide sulfonate plus conventional therapy)
Number of subjects: 46
Study 25960284 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 46
Study 24067111 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal tube cuff pressure maintained at 20 mm Hg after retractor placement
Number of subjects: 177
Study 24067111 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal tube cuff pressure not adjusted after retractor placement
Number of subjects: 177
Study 21843745 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 1023
Study 21843745 — intervention group
Group type: COMPARATOR
Intervention: Work and Social Adjustment Scale (WSAS)
Number of subjects: 1023
Study 19478701 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anesthesia (n=41)
Number of subjects: 83
Study 19478701 — intervention group
Group type: COMPARATOR
Intervention: Halothane anesthesia (n=42)
Number of subjects: 83
Study 17955786 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (EPA and DHA)
Number of subjects: 0
Study 14765872 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal Femoral Nail (PFN)
Number of subjects: 424
Study 14765872 — intervention group
Group type: COMPARATOR
Intervention: Gamma Nail (GN)
Number of subjects: 424
Study 11701070 — intervention group
Group type: EXPERIMENTAL
Intervention: Megadose steroid therapy (group S)
Number of subjects: 31
Study 11701070 — intervention group
Group type: COMPARATOR
Intervention: Lipoprostaglandin E(1) therapy (group L)
Number of subjects: 31
Study 9337183 — intervention group
Group type: EXPERIMENTAL
Intervention: KCl infusion (maximum, 40 mEq) in healthy subjects treated with quinidine sulfate
Number of subjects: 20
Study 9337183 — intervention group
Group type: EXPERIMENTAL
Intervention: KCl infusion (maximum, 40 mEq) in CHF patients
Number of subjects: 20
Study 9337183 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 20
Study 7887823 — intervention group
Group type: EXPERIMENTAL
Intervention: Filling the dialysis circuit with 6.7% human albumin in saline for 10 min at a flow rate of 100 ml/min before HD
Number of subjects: 8
Study 7887823 — intervention group
Group type: COMPARATOR
Intervention: Standard hemodialysis without albumin
Number of subjects: 8
Study 7887823 — intervention group
Group type: EXPERIMENTAL
Intervention: Filling the dialysis circuit with albumin
Number of subjects: 8
Study 3126634 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin (NTG) 10 mg
Number of subjects: 10
Study 3126634 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin (NTG) 5 mg
Number of subjects: 10
Study 3126634 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31410887 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-Start intervention (before-school physical activity program for 8 weeks)
Number of subjects: 170
Study 30217412 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncology rehabilitation with motivational interviewing delivered once weekly for 7 weeks via telephone by a physiotherapist
Number of subjects: 46
Study 30217412 — intervention group
Group type: COMPARATOR
Intervention: Oncology rehabilitation
Number of subjects: 46
Study 30217412 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncology rehabilitation with motivational interviewing
Number of subjects: 46
Study 28218557 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial 2C (surgical procedure for primary palatal repair)
Number of subjects: 448
Study 28218557 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial 3D (surgical procedure for primary palatal repair)
Number of subjects: 448
Study 28218557 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial 3A (surgical procedure for primary palatal repair)
Number of subjects: 448
Study 26187456 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronabinol 30 mg/d
Number of subjects: 60
Study 26187456 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 26187456 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who smoked marijuana
Number of subjects: 60
Study 23725999 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (10 mg/d) with concurrent radiation (60 Gy in 30 fractions) and temozolomide (75 mg/m2 per day)
Number of subjects: 25
Study 20979460 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure (eight treatments over 4 weeks)
Number of subjects: 0